- Home
- ABBV vs JPM Comparison
ABBV vs JPM Comparison
Compare ABBV & JPM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABBV | JPM |
|---|---|---|
| Founded | 2012 | 1799 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 451.5B | 880.6B |
| IPO Year | 2012 | 2025 |
Fundamental Metrics
Financial Performance| Metric | ABBV | JPM |
|---|---|---|
| Price | $285.48 | $338.69 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 30 | 26 |
| Target Price | $282.61 | ★ $372.57 |
| AVG Volume (30 Days) | 2.8M | ★ 7.3M |
| Earning Date | 10-30-2026 | 10-13-2026 |
| Dividend Yield | ★ 2.44% | 1.97% |
| EPS Growth | N/A | ★ 1.37 |
| EPS | 2.42 | ★ 13.63 |
| Revenue | $61,160,000,000.00 | ★ $182,447,000,000.00 |
| Revenue This Year | $10.57 | $13.98 |
| Revenue Next Year | $8.79 | $4.02 |
| P/E Ratio | $116.90 | ★ $24.61 |
| Revenue Growth | ★ 8.57 | 2.75 |
| 52 Week Low | $190.75 | $279.10 |
| 52 Week High | $291.40 | $366.50 |
Technical Indicators
Market Signals| Indicator | ABBV | JPM |
|---|---|---|
| Relative Strength Index (RSI) | 70.76 | 49.56 |
| Support Level | $243.68 | $325.28 |
| Resistance Level | N/A | $343.45 |
| Average True Range (ATR) | 6.49 | 5.54 |
| MACD | 1.68 | 1.04 |
| Stochastic Oscillator | 81.17 | 70.98 |
Price Performance
Historical ComparisonAbout ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
About JPM JP Morgan Chase & Co.
JPMorgan is a leading global financial services firm with operations in 66 countries and over 320,000 employees as of June 2026. Under the JPMorgan brands, the bank holding company boasts a $5.0 trillion balance sheet and $2.71 trillion in deposits, as of June 2026. The firm generates its revenue across three core operating segments: consumer and community banking, the commercial and investment bank, and asset and wealth management. It maintains the top global ranking in investment banking fees with an 8.4% market share, serves millions of consumers through its network of over 5,000 US branches, and manages over $7.6 trillion in client assets within its wealth and asset management franchise.